Berhanu, R.

Publications

53

Citations

899

h-index

18

Publishing journals

32

Years of publications

14

Active since

2013

References

1.2K

Institutions

8

1. Mapping the potential and limitations of using generative AI technologies to address socio-economic challenges in LMICs
   Nature Computational Science, Year 2026
2. Breaking barriers: harnessing artificial intelligence for a stigma-free, efficient HIV prevention assessment among adults in South Africa
   Frontiers in Digital Health, Volume 7, No. 1731002, Pages 1731002-1731002, Year 2026
3. Prolonged Diagnostic Interval Leads to High Lymphoma Related Mortality in a Prospective Cohort of People with HIV Undergoing Fine Needle Aspiration
   Cancers, Volume 17, Issue 6, No. 1005, Page 1005, Year 2025
4. Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update
   Southern African Journal of HIV Medicine, Volume 25, Issue 1, Year 2024
5. Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa
   Clinical Infectious Diseases, Volume 76, Issue 9, Pages 1594-1603, Year 2023
6. Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial)
   PLoS Medicine, Volume 20, Issue 5 May, No. e1004237, Page e1004237, Year 2023
7. The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes
   JAIDS Journal of Acquired Immune Deficiency Syndromes, Volume 94, Issue 2S, Pages S42-S46, Year 2023
8. Pulmonary tuberculosis vs. Tindzhaka and Mafularha: A mixed methods inquiry of traditional healers’ perceptions of tuberculosis in rural South Africa
   PLOS Global Public Health, Volume 3, Issue 4 April, No. e0001611, Page e0001611, Year 2023
9. Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial
   SSRN Electronic Journal, Year 2022
10. A Cluster Randomized Trial of Systematic Targeted Universal Testing for Tuberculosis in Primary Care Clinics of South Africa (The TUTT Study)
    SSRN Electronic Journal, Year 2022
11. Reprocessing Of Legacy Seismic Profile For Shale Gas Exploration In The Karoo Basin (South Africa)
    28th European Meeting of Environmental and Engineering Geophysics, Held at the Near Surface Geoscience Conference and Exhibition 2022, NSG 2022, Pages 1-5, Year 2022
12. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
    BMC Pregnancy and Childbirth, Volume 21, Issue 1, No. 453, Year 2021
13. Tuberculosis Preventive Therapy for People With HIV Infection in High Tuberculosis Burden Settings: How Much Is Enough?
    Annals of Internal Medicine, Volume 174, Issue 10, Pages 1462-1463, Year 2021
14. Managing multidrug-resistant tuberculosis in South Africa: A budget impact analysis
    The International Journal of Tuberculosis and Lung Disease, Volume 24, Issue 4, Pages 376-382, Year 2020
15. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
    UNC Libraries, Year 2020
16. A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis
    UNC Libraries, Year 2020
17. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa
    Health and Quality of Life Outcomes, Volume 17, Issue 1, No. 94, Pages 94-94, Year 2019
18. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
    BMC Public Health, Volume 19, Issue 1, Pages 973-973, Year 2019
19. Discordant rifampicin susceptibility results are associated with Xpert ® MTB/RIF probe B and probe binding delay
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Volume 22, Issue 8, Pages 358-362, Year 2019
20. Discordant rifampicin susceptibility results are associated with Xpert ® MTB/RIF probe B and probe binding delay
    The International Journal of Tuberculosis and Lung Disease, Volume 23, Issue 3, Pages 358-362, Year 2019

No publications in the index yet.